Journal of Clinical Oncologyжурнал

Статьи, опубликованные в журнале

---

• 
  • 2022 Antitumor effectiveness of combination therapy with platinum and hybrid organotin compound on the Lewis epidermoid carcinoma model with metronomic administration
  • Kotieva I.M., Dodokhova M.A., Safronenko A.V., Alkhuseyn-Kulyaginova M.S., Milaeva E.R., Nikitin E.A., Shpakovsky D.B., Kotieva E.М., Kotieva V.М., Starostin S.I.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 40, № 16 suppl., с. e15080-e15080 DOI
• 
  • 2022 Antitumor pharmacological activity of hybrid organotin compounds on the Lewis epidermoid carcinoma model
  • Dodokhova M.A., Kotieva I.M., Safronenko A.V., Alkhuseyn-Kulyaginova M.S., Kotieva E.М., Kotieva V.М., Starostin S.I., Nikitin E.A., Shpakovsky D.B., Milaeva E.R.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 40, № 16 suppl., с. e15004-e15004 DOI
• • 2022 Evaluation of treatment patterns in patients with BRAF-mutant cutaneous melanoma in adjuvant setting in real practice
  • Samoylenko Igor, Stroganova Anna, Shakhray Ekaterina, Orlova Kristina V., Akhmetianova Angelina, Demidov Lev V.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 40, № 16_suppl, с. e21573-e21573 DOI
• • 2022 Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study
  • Gilberto de Castro Jr, Kudaba Iveta, Wu Yi-Long, Lopes Gilberto, Kowalski Dariusz M., Turna Hande Z., Caglevic Christian, Li Zhang, Karaszewska Boguslawa, Laktionov Konstantin K., Srimuninnimit Vichien, Bondarenko Igor, Kubota Kaoru, Mukherjee Rinee, Lin Jianxin, Souza Fabricio, Mok Tony S.K., Cho Byoung Chul
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), с. 1-7
• • 2022 Multicenter prospective clinical trial of molecular genetic markers for non-invasive differential diagnosis of benign and malignant melanocytic skin lesions
  • Samoylenko Igor, Zaretsky Andrew R., Chudakova Lidia V., Drozd Oleg V., Garanina Oksana E., Shlivko Irena L., Zinovev Grigory, Baryshnikov Kirill A., Orlova Kristina V., Maximova Tatiana, Sinelnikov Igor, Kim Anna, Mikhaylova Irina N., Demidov Lev V.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 40, № 16_suppl, с. e21581-e21581 DOI
• • 2022 Platinum vs non-platinum chemotherapy for platinum-resistant ovarian cancer: A meta-analysis
  • Rumyantsev Alexey, Tyulyandina Alexandra, Fedyanin Mikhail, Pokataev Ilya, Glazkova Elena, Israelyan Edgar, Tjulandin Sergei
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 40, № 16, с. e17551
• • 2022 Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma
  • Chesney Jason A., Ribas Antoni, Long Georgina V., Kirkwood John M., Dummer Reinhard, Puzanov Igor, Hoeller Christoph, Gajewski Thomas F., Gutzmer Ralf, Rutkowski Piotr, Demidov Lev, Arenberger Petr, Shin Sang Joon, Ferrucci Pier Francesco, Haydon Andrew, Hyngstrom John, van Thienen Johannes V., Haferkamp Sebastian, Guilera Josep Malvehy, Rapoport Bernardo Leon, VanderWalde Ari, Diede Scott J., Anderson James R., Treichel Sheryl, Chan Edward L., Bhatta Sumita, Gansert Jennifer, Hodi Frank Stephen, Gogas Helen
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States) DOI
• • 2022 Reconstructing the tumor microenvironment to unlock therapeutic options in pancreatic cancer
  • George Ben, Thalji Samih, Malarkannan Subramaniam, Kudryashova Olga, Kravets Andrey, Gusakova Mariia, Kravchenko Dmitry, Tychinin Dmitry, Frenkel Felix, Bagaev Aleksander, Shin Nara, Mehdi Maahum, Kamgar Mandana, Hall William A., Erickson Beth, Christians Kathleen K., Evans Douglas B., Tsai Susan
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 40, № 4_suppl, с. 589-589 DOI
• • 2022 Short-term preoperative endocrine therapy allows to estimate and revert patient prognosis with further treatment plan correction in HR$\mathplus$ HER2- early breast cancer patients
  • Zhukova Lyudmila, Ganshina Inna, Ignatieva Maria, Ivanyuk Maria, Kolyadina Irina Vladimirovna, Kvetenadze Gurami, Valeeva Alexandra, Sorokina Irina
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 40, № 16_suppl, с. e12628-e12628 DOI
• • 2022 Study of the level of tumor markers and mutations in the BRCA1/2 genes in breast cancer patients with metachronous tumors
  • Kamishov Sergey Viktorovich, Izrailbekova Kamila Shavkatovna, Balenkov Oleg Yurievich
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 40, № 16_suppl, с. e12563 DOI
• • 2022 The role of surgery (metastasectomy) in advanced BRAF positive melanoma during modern therapy
  • Orlova Kristina V., Ledin Evgeny, Zhukova Natalia V., Orlova Rashida, Protsenko Svetlana, Novik Alexey, Moiseenko Fedor Vladimirovich, Naskhletashvili David, Demidov Lev V.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 40, № supl 16 DOI
• • 2022 Two-year update from KEYNOTE-799: Pembrolizumab plus concurrent chemoradiation therapy (cCRT) for unresectable, locally advanced, stage III NSCLC
  • Reck Martin, Lee Ki Hyeong, Frost Nicolaj, Breder Valeriy Vladimirovich, Kowalski Dariusz, Levchenko Evgeny, Reguart Noemi, Martinez-Marti Alex, Houghton Baerin, Paoli Jean-Baptiste, Safina Sufiia, Komiya Takefumi, Sanford Amy, Liu Hong, Song Andrew J., Keller Steven M., Jabbour Salma K.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 40, № 16_suppl, с. 8508-8508 DOI
• • 2022 Utility of public Knowledge Bases (KB) for comprehensive tumor molecular profiling (CTMP) result interpretation
  • Lebedeva Alexandra, Ivanov Maxim, Ignatova Ekaterina, Timokhin Grigoriy, Sharova Margarita, Mileyko Vladislav, Yakushina Valentina, Olesya Kuznetsova, Stepanova Maria, Shilo Polina, Moiseenko Fedor Vladimirovich, Volkov Nikita, Plaksa Igor, Isaev Andrey, Gayryan Margarita, Pokataev Ilya, Rumyantsev Alexey, Ledin Evgeny, Tryakin Alexey, Fedyanin Mikhail
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 40, № 16, с. e15119
• 
  • 2021 Antimetastatic effect of organotin compounds on the model of melanoma B16 in the experiment
  • Dodokhova M.A., Kotieva I.M., Shpakovsky D.B., Safronenko A.V., Komarova E.F., Alkhuseyn-Kulyaginova M.S., Milaeva E.R., Shtil A.A.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 39, № 15_suppl, с. e21564-e21564 DOI
• 
  • 2021 Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma
  • Kumar R., KS Smith, Deng M., Terhune C., GW Robinson, BA Orr, APY Liu, Lin T., Billups CA, Chintagumpala M., Bowers DC, Hassall TE, Hansford JR, Khuong-Quang DA, Crawford JR, Bendel AE, Gururangan S., Schroeder K., Bouffet E., Bartels U., MJ Fisher, Cohn R., Partap S., SJ Kellie, McCowage G., AC Paulino, Rutkowski S., Fleischhack G., Dhall G., Klesse LJ, Leary S., Nazarian J., Kool M., Wesseling P., Ryzhova M., Zheludkova O., Golanov AV, McLendon RE, Packer RJ, Dunham C., Hukin J., Fouladi M., CC Faria, Pimentel J., AW Walter, Jabado N., Cho YJ, Perreault S., Croul SE, Zapotocky M., Hawkins C., Tabori U., Taylor MD, Pfister SM, Klimo P.Jr, Boop FA, Ellison DW, Merchant TE, Onar-Thomas A., Korshunov A., Jones DTW, Gajjar A., Ramaswamy V., Northcott PA
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), № 39 (7), с. 807-821 DOI
• 
  • 2021 Efficacy of first-line treatments for patients (pts) with advanced EGFR mutated NSCLC: Network meta-analysis of TKI monotherapy and combinations trials
  • Bogdanov Alexey, Moiseenko Fedor Vladimirovich, Zhabina Albina, Volkov Nikita, Artem\textquotesingleeva Elizaveta, Fedyanin Mikhail
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 39, № 15_suppl, с. e21120-e21120 DOI
• 
  • 2021 Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
  • Glasbey James C., Bhangu Aneel, Garmanova T., Agapov M., Markaryan D., Kamalov A., Kubishkin V.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 39, № 1, с. 66-78 DOI
• 
  • 2021 Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
  • Glasbey James C., Bhangu Aneel, Garmanova T., Agapov M., Markaryan D., Kamalov A., Kubishkin V., kakotkin V.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 39, № 1, с. 66-78 DOI
• 
  • 2021 Metastasectomy in colorectal carcinoma (CRC) patients (pts) with mBRAF: Prospective database analysis
  • Fedyanin Mikhail, Elsnukaeva Kheda, Demidova Irina, Stroyakovskiy Daniil, Shelygin Yuri, Tsukanov Alexey, Panina Maria V., Shubin Vitaliy, Moiseenko Fedor Vladimirovich, Karpenko Elena, Bolotina Larisa, Kudryavtseva Anna, Filipenko Maxim, Vladimirova Liubov Yu, Timoshkina Natalya N., Kit Oleg I., Stroganova Anna, Dranko Svetlana, Tryakin Alexey, Tjulandin Sergei
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 39, № 15_suppl, с. e15549-e15549 DOI
• 
  • 2021 Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma
  • McDermott David F., Lee Jae-Lyun, Ziobro Marek, Suarez Cristina, Langiewicz Przemyslaw, Matveev Vsevolod Borisovich, Wiechno Pawel, Gafanov Rustem Airatovich, Tomczak Piotr, Pouliot Frederic, Donskov Frede, Alekseev Boris Yakovlevich, Shin Sang Joon, Bjarnason Georg A., Castellano Daniel, Silverman Rachel Kloss, Perini Rodolfo F., Schloss Charles, Atkins Michael B.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 39, № 9, с. 1029-1039 DOI
• 
  • 2021 Organotin compounds as effective antimetastatic substances in the treatment of epidermoid lung carcinoma Lewis (LLC) in an experiment
  • Dodokhova M.A., Kotieva I.M., Safronenko A.V., Shpakovsky D.B., Milaeva E.R., Shtil A.A., Komarova E.F., Alkhuseyn-Kulyaginova M.S.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 39, № 15_suppl, с. e15054-e15054 DOI
• 
  • 2021 Pazopanib in the advanced and rare subtypes of soft tissue sarcoma: Russian Sarcoma Group study
  • Tararykova Anastasia Alekseevna, Bokhyan Beniamin, Konev Andrey A., Falkina Polina A., Kumekhov Zaur Yu, Valiev Aslan K.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 39, № 15_suppl, с. e23528-e23528 DOI
• 
  • 2021 Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
  • Gillessen Silke, Sauvé Nicolas, Collette Laurence, Daugaard Gedske, de Wit Ronald, Albany Costantine, Tryakin Alexey, Fizazi Karim, Stahl Olof, Gietema Jourik A., De Giorgi Ugo, Cafferty Fay H., Hansen Aaron R., Tandstad Torgrim, Huddart Robert A., Necchi Andrea, Sweeney Christopher J., Garcia-Del-Muro Xavier, Heng Daniel Y.C., Lorch Anja, Chovanec Michal, Winquist Eric, Grimison Peter, Feldman Darren R., Terbuch Angelika, Hentrich Marcus, Bokemeyer Carsten, Negaard Helene, Fankhauser Christian, Shamash Jonathan, Vaughn David J., Sternberg Cora N., Heidenreich Axel, Beyer Jörg
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 39, № 14, с. 1563-1574 DOI
• 
  • 2021 Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
  • Beyer Jörg, Collette Laurence, Sauvé Nicolas, Daugaard Gedske, Feldman Darren R., Tandstad Torgrim, Tryakin Alexey, Stahl Olof, Gonzalez-Billalabeitia Enrique, De Giorgi Ugo, Culine Stéphane, de Wit Ronald, Hansen Aaron R., Bebek Marko, Terbuch Angelika, Albany Costantine, Hentrich Marcus, Gietema Jourik A., Negaard Helene, Huddart Robert A., Lorch Anja, Cafferty Fay H., Heng Daniel Y.C., Sweeney Christopher J., Winquist Eric, Chovanec Michal, Fankhauser Christian, Stark Daniel, Grimison Peter, Necchi Andrea, Tran Ben, Heidenreich Axel, Shamash Jonathan, Sternberg Cora N., Vaughn David J., Duran Ignacio, Bokemeyer Carsten, Patrikidou Anna, Cathomas Richard, Assele Samson, Gillessen Silke
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 39, № 14, с. 1553-1562 DOI
• • 2020 A PHASE II PILOT STUDY OF THE EFFICACY AND SAFETY OF NIVOLUMAB AND IPILIMUMAB IN T1AN0M0 RENAL CELL CARCINOMA PATIENTS INELIGIBLE FOR SURGICAL TREATMENT
  • Timofeev I.V., Volkova M.I., Gafanov R.A., Nosov D.A., Bex A.
  • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 38, № S6, с. 769-769